Archives for: September 28th, 2017

CorMedix Inc. to Present at The MicroCap Conference

Written by Josh Drumm, Ph.D. on September 28, 2017

Bedminster, NJ – September 28, 2017 – CorMedix Inc. (NYSE…

CorMedix Inc. Relocates Corporate Headquarters

Written by Josh Drumm, Ph.D. on September 25, 2017

Berkeley Heights, NJ – September 25, 2017 – CorMedix Inc….

CorMedix Inc. to Present at the Anti-Infectives Rx Conference

Written by Josh Drumm, Ph.D. on September 12, 2017

Bedminster, NJ – September 12, 2017 – CorMedix Inc. (NYSE…

CorMedix Inc. Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris

Written by Josh Drumm, Ph.D. on September 7, 2017

Poster Presented at the ASM/ESCMID Conference on Drug Development to…

CorMedix Inc. to Present at 2017 Rodman & Renshaw 19th Annual Global Investment Conference

Written by Josh Drumm, Ph.D. on September 5, 2017

Bedminster, NJ – September 5, 2017 – CorMedix Inc. (NYSE…